ANKRD44 and non-small cell lung carcinoma: In line with the expression levels in the low-RS group, the increased expression of POU2AF1, CRTAM, and ANKRD44 was observed in the patients with irAEs, suggesting the potential of RS to predict irAEs in NSCLC.